Multi-omics analysis to identify lung squamous carcinoma lactate metabolism-related subtypes and establish related index to predict prognosis and guide immunotherapy

免疫疗法 免疫系统 肿瘤微环境 肺癌 生物 重编程 肿瘤科 内科学 医学 癌症研究 免疫学 细胞 遗传学
作者
Chenghao Wang,Tong Lu,Ran Xu,Shan Luo,Jiaying Zhao,Linyou Zhang
出处
期刊:Computational and structural biotechnology journal [American Association for the Advancement of Science]
卷期号:20: 4756-4770
标识
DOI:10.1016/j.csbj.2022.08.067
摘要

Lung squamous carcinoma (LUSC) is a malignant tumor of the respiratory system with highly heterogeneous characteristics. Lactate is the main product of aerobic glycolysis during the metabolic reprogramming of tumors. There is growing evidence that lactate metabolic processes have a broad and sophisticated impact on tumor phenotypic plasticity and tumor microenvironment (TME). However, the pattern of lactate metabolism in patients with LUSC and its impact on TME, phenotype, prognosis, and treatment have not been fully elucidated. In this study, we identified two subtypes with different lactate metabolism patterns in LUSC by non-negative matrix factorization and explored their multi-omics features. We observed that lactate metabolism levels in LUSC extensively influenced tumor immune infiltration patterns, adaptation to the hypoxia environment, and energy metabolic reprogramming. Subsequently, we constructed the lactate metabolism-related prognostic index (LMRPI) using Cox stepwise regression analysis. LMRPI showed excellent stability and accuracy, and based on the median value of LMRPI, LUAD were divided into two subgroups. The two subgroups have different patterns of immune infiltration and somatic mutations. Meanwhile, the two subgroups had different responsiveness to immune checkpoint inhibitor (ICI) therapies and different sensitivity to various chemotherapeutic and molecular targeting agents. In conclusion, we defined two subtypes with different lactate metabolism patterns in LUSC and extensively characterized their multi-omics profile. Furthermore, we developed LMRPI that predicts the prognosis of LUSC patients while also predicting their response to various adjuvant therapies, including immunotherapy, to guide their individualized treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可可完成签到 ,获得积分10
刚刚
CipherSage的应助被muderder采纳,获得10
刚刚
1秒前
轻松峻熙发布了新的文献求助10
2秒前
科研通AI6.4的应助被ygy采纳,获得10
2秒前
贾贡献的应助被十二采纳,获得10
2秒前
迟宏珈发布了新的文献求助10
4秒前
文静迎南发布了新的文献求助10
5秒前
5秒前
5秒前
6秒前
CipherSage的应助被hyska采纳,获得10
6秒前
陈红安完成签到,获得积分10
7秒前
7秒前
巨小俊完成签到,获得积分10
8秒前
WT发布了新的文献求助10
9秒前
道天完成签到,获得积分10
10秒前
轻松峻熙完成签到,获得积分10
11秒前
谢富杰发布了新的文献求助10
11秒前
jiashan发布了新的文献求助30
11秒前
xh发布了新的文献求助10
12秒前
LeeStrife完成签到 ,获得积分10
12秒前
13秒前
13秒前
斯文败类的应助被科研通管家采纳,获得10
13秒前
无花果的应助被科研通管家采纳,获得10
13秒前
共享精神的应助被科研通管家采纳,获得10
13秒前
星辰大海的应助被科研通管家采纳,获得10
13秒前
NexusExplorer的应助被科研通管家采纳,获得10
13秒前
小二郎的应助被科研通管家采纳,获得10
13秒前
molihuakai的应助被科研通管家采纳,获得10
14秒前
14秒前
JamesPei的应助被科研通管家采纳,获得10
14秒前
Hello的应助被科研通管家采纳,获得10
14秒前
852的应助被科研通管家采纳,获得10
14秒前
15秒前
tib完成签到,获得积分10
15秒前
谢富杰完成签到,获得积分10
16秒前
WKD完成签到,获得积分10
16秒前
jhm完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188394
求助须知:如何正确求助?哪些是违规求助? 9576268
关于积分的说明 21846207
捐赠科研通 7786486
什么是DOI,文献DOI怎么找? 3435317
关于科研通互助平台的介绍 2559618
邀请新用户注册赠送积分活动 2482322